FDAnews
www.fdanews.com/articles/84900-lupin-aspen-sign-mou-for-anti-tb-jv

LUPIN-ASPEN SIGN MOU FOR ANTI-TB JV

February 28, 2006

Lupin Limited and Aspen Pharmacare Holdings Ltd., South Africa have entered into a Memorandum of Understanding for the establishment a 50:50 Joint Venture for the development, manufacture and global marketing (except US, South Africa & India Trade) of selected Anti-TB products. While Lupin has traditional strengths in Anti-TB formulations and Active Pharmaceutical Ingredients (APIs), Aspen will bring a range of MDR-TB products to the Venture.

India Infoline (http://www.indiainfoline.com/news/news.asp?dat=76613)